Skip to main content
Log in

Distribution of metabolic/obese phenotypes and association with diabetes: 5 years’ cohort based on 22,276 elderly

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Aims

To describe the distribution and changes of different metabolic/obese phenotypes among more than 22,000 male elderly in China, and also explore the association with diabetes incidence.

Methods

A cohort study based on 22,276 male elderly was conducted in Beijing, from 2009 to 2013. Multiple Cox model was used to calculate the relative risk.

Results

There were only 53.8% of total participants who kept the same phenotype for the 5 years. On the whole, participants with metabolically unhealthy phenotypes had higher relative risks (RRs) than those with metabolically healthy phenotypes. RRs for diabetes showed an increasing trend along with metabolic abnormalities (p < 0.001). However, no statistically significant difference was found across different obese status with the same number of metabolic abnormalities. Changes of metabolic/obese status also showed the same trend. Those who had kept metabolic unhealthy had the highest RRs for diabetes incidence, which was higher than those who kept obesity.

Conclusions

Both metabolically healthy obesity and metabolically unhealthy normal weight phenotypes had an increased risk for diabetes incidence, and metabolic abnormalities might have more influence on diabetes than obesity itself. Changes of metabolic/obese status also had an important impact on diabetes incidence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Abbreviations

BMI:

Body mass index

CI:

Confidence interval

DBP:

Diastolic blood pressure

FBG:

Fasting blood glucose

HDL-C:

High-density lipoprotein cholesterol

LDL-C:

Low-density lipoprotein cholesterol

MHNW:

Metabolically healthy normal weight

MHO:

Metabolically healthy obesity

MHOW:

Metabolically healthy overweight

MUNW:

Metabolically unhealthy normal weight

MUO:

Metabolically unhealthy obesity

MUOW:

Metabolically unhealthy overweight

RR:

Relative risk

SBP:

Systolic blood pressure

TC:

Total cholesterol

TG:

Triglyceride

2hPG:

Two hours plasma glucose

References

  1. R. Viner, B. White, D. Christie, Type 2 diabetes in adolescents: a severe phenotype posing major clinical challenges and public health burden. Lancet 389, 2252–2260 (2017)

    Article  PubMed  Google Scholar 

  2. S.L. Hardoon, R.W. Morris, M.C. Thomas, S.G. Wannamethee, L.T. Lennon, P.H. Whincup, Is the recent rise in type 2 diabetes incidence from 1984 to 2007 explained by the trend in increasing BMI?: evidence from a prospective study of British men. Diabetes Care 33, 1494–1496 (2010)

    Article  PubMed  PubMed Central  Google Scholar 

  3. A. Abdullah, A. Peeters, M.D. Courten, J. Stoelwinder, The magnitude of association between overweight and obesity and the risk of diabetes: a meta-analysis of prospective cohort studies. Diabetes Res. Clin. Pract. 89, 309–319 (2010)

    Article  PubMed  Google Scholar 

  4. L.C. Hwang, C.H. Bai, C.A. Sun, C.J. Chen, Prevalence of metabolically healthy obesity and its impacts on incidences of hypertension, diabetes and the metabolic syndrome in Taiwan. Asia Pac. J. Clin. Nutr. 21, 227–233 (2012)

    CAS  PubMed  Google Scholar 

  5. A.D. Karelis, D.H. St-Pierre, F. Conus, R. Rabasa-Lhoret, E.T. Poehlman, Metabolic and body composition factors in subgroups of obesity: what do we know? J. Clin. Endocrinol. Metab. 89, 2569–2575 (2004)

    Article  CAS  PubMed  Google Scholar 

  6. Y. Chang, S. Ryu, Y. Choi, Y. Zhang, J. Cho, M.J. Kwon, Y.Y. Hyun, K.B. Lee, H. Kim, H.S. Jung, K.E. Yun, J. Ahn, S. Rampal, D. Zhao, B.S. Suh, E.C. Chung, H. Shin, R. Pastor-Barriuso, E. Guallar, Metabolically healthy obesity and development of chronic kidney disease: a cohort study. Ann. Intern. Med. 164, 305–312 (2016)

    Article  PubMed  Google Scholar 

  7. Y. Chang, B.K. Kim, K.E. Yun, J. Cho, Y. Zhang, S. Rampal, D. Zhao, H.S. Jung, Y. Choi, J. Ahn, J.A. Lima, H. Shin, E. Guallar, S. Ryu, Metabolically-healthy obesity and coronary artery calcification. J. Am. Coll. Cardiol. 63, 2679–2686 (2014)

    Article  PubMed  Google Scholar 

  8. N. Eckel, K. Mühlenbruch, K. Meidtner, H. Boeing, N. Stefan, M.B. Schulze, Characterization of metabolically unhealthy normal-weight individuals: risk factors and their associations with type 2 diabetes. Metab. Clin. Exp. 64, 862–871 (2015)

    Article  CAS  PubMed  Google Scholar 

  9. A. Goday, E. Calvo, L.A. Vázquez, E. Caveda, T. Margallo, C. Catalina-Romero, J. Reviriego, Prevalence and clinical characteristics of metabolically healthy obese individuals and other obese/non-obese metabolic phenotypes in a working population: results from the Icaria study. BMC Public Health 16, 248 (2016)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. H.K. Nan, A.S. Ji, H. Cho, J.H. Seo, J.H. Yu, H.J. Yoo, S.G. Kim, K.M. Choi, S.H. Baik, D.S. Choi, C. Shin, N.H. Cho, Risk of the development of diabetes and cardiovascular disease in metabolically healthy obese people: the Korean genome and epidemiology study. Medicine 95, e3384 (2016)

    Article  CAS  Google Scholar 

  11. M. Liu, J. Wang, J. Zeng, X. Cao, Y. He, Association of NAFLD with diabetes and the impact of BMI changes: a 5 years’ cohort study based on 18507 elderly. J. Clin. Endocrinol. Metab. 102, 1309 (2017)

    Article  PubMed  Google Scholar 

  12. K.G. Alberti, R.H. Eckel, S.M. Grundy, P.Z. Zimmet, J.I. Cleeman, K.A. Donato, J.C. Fruchart, W.P. James, C.M. Loria, S.C. Smith Jr; International Diabetes Federation Task Force on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity, Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International. Circulation 120, 1640 (2009)

    Article  CAS  PubMed  Google Scholar 

  13. G. Calori, G. Lattuada, L. Piemonti, M.P. Garancini, F. Ragogna, M. Villa, S. Mannino, P. Crosignani, E. Bosi, L. Luzi, G. Ruotolo, G. Perseghin, Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study. Diabetes Care 34, 210 (2011)

    Article  PubMed  Google Scholar 

  14. E.J. Rhee, M.K. Lee, J.D. Kim, W.S. Jeon, J.C. Bae, S.E. Park, C.Y. Park, K.W. Oh, S.W. Park, W.Y. Lee, Metabolic health is a more important determinant for diabetes development than simple obesity: a 4-year retrospective longitudinal study. PLoS ONE 9, e98369 (2014)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. S.L. Appleton, C.J. Seaborn, R. Visvanathan, C.L. Hill, T.K. Gill, A.W. Taylor, R.J. Adams, North West Adelaide Health Study Team. Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype. Diabetes Care 36, 2388 (2013)

    Article  PubMed  PubMed Central  Google Scholar 

  16. G.M. Hinnouho, S. Czernichow, A. Dugravot, H. Nabi, E.J. Brunner, M. Kivimaki, A. Singh-Manoux, Metabolically healthy obesity and the risk of cardiovascular disease and type 2 diabetes: the Whitehall II cohort study. Eur. Heart J. 36, 551–559 (2015)

    Article  PubMed  Google Scholar 

  17. Y. Heianza, K. Kato, S. Kodama, A. Suzuki, S. Tanaka, O. Hanyu, K. Sato, H. Sone, Stability and changes in metabolically healthy overweight or obesity and risk of future diabetes: Niigata wellness study. Obesity 22, 2420–2425 (2014)

    Article  PubMed  Google Scholar 

  18. K. Aung, C. Lorenzo, M.A. Hinojosa, S.M. Haffner, Risk of developing diabetes and cardiovascular disease in metabolically unhealthy normal-weight and metabolically healthy obese individuals. J. Clin. Endocrinol. Metab. 99, 462–468 (2014)

    Article  CAS  PubMed  Google Scholar 

  19. C.K. Kramer, B. Zinman, R. Retnakaran, Are metabolically healthy overweight and obesity benign conditions?: a systematic review and meta-analysis. Ann. Intern. Med. 159, 758–769 (2013)

    Article  PubMed  Google Scholar 

  20. L.L. Roberson, E.C. Aneni, W. Maziak, A. Agatston, T. Feldman, M. Rouseff, T. Tran, M. Blaha, R. Santos, A. Sposito, M. Al-Mallah, R. Blankstein, M. Budoff, K. Nasir, Beyond BMI: the “metabolically healthy obese” phenotype & its association with clinical/subclinical cardiovascular disease and all-cause mortality—a systematic review. BMC Public Health 14, 14 (2014)

    Article  PubMed  PubMed Central  Google Scholar 

  21. F. Badoud, M. Perreault, M.A. Zulyniak, D.M. Mutch, Molecular insights into the role of white adipose tissue in metabolically unhealthy normal weight and metabolically healthy obese individuals. FASEB J. 29, 748–758 (2015)

    Article  CAS  PubMed  Google Scholar 

  22. N. Freemantle, J. Holmes, A. Hockey, S. Kumar, How strong is the association between abdominal obesity and the incidence of type 2 diabetes?. Int. J. Clin. 62, 1391–1396 (2008)

    Article  CAS  Google Scholar 

  23. M.J. Mcneely, J.B. Shofer, D.L. Leonetti, W.Y. Fujimoto, E.J. Boyko, Associations among visceral fat, all-cause mortality, and obesity-related mortality in Japanese Americans. Diabetes Care 35(2), 296–298 (2012)

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This study is supported by research grants from Beijing Nova Program (Z181100006218085), Opening Foundation of State Key Laboratory of Kidney Diseases (KF-01-115), Opening Foundation of National Clinical Research Center of Geriatrics (NCRCG-PLAGH-2017017), National Natural Science Foundation of China (81703285), Beijing Natural Science Foundation (7174350), Beijing Municipal Science and Technology Commission (Z161100005016021), Military Fund (15BJZ41, 17BJZ51). The views and opinions expressed in this paper are those of the authors and do not necessarily reflect the official position of the study sponsors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Miao Liu.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. And this study protocol had been approved by the Ethics Committees of Chinese PLA General Hospital (EC0411-2001).

Informed consent

Informed consent was obtained from all individual participants included in the study.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, M., Tang, R., Wang, J. et al. Distribution of metabolic/obese phenotypes and association with diabetes: 5 years’ cohort based on 22,276 elderly. Endocrine 62, 107–115 (2018). https://doi.org/10.1007/s12020-018-1672-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-018-1672-7

Keywords

Navigation